Study of the Safety and Efficacy of Elagolix in Women With Polycystic Ovary Syndrome

Status:
Completed

Trial end date:
2021-02-10

Target enrollment:

Participant gender:

This study will assess the potential impact of Elagolix on disordered pituitary and ovarian hormones in women with Polycystic Ovary Syndrome (PCOS).

Phase 2

AbbVie